Osteoporosis Complicating Some Inborn or Acquired Diseases

被引:1
|
作者
Zofkova, I. [1 ]
Nemcikova, P. [2 ]
机构
[1] Inst Endocrinol, Narodni 8, Prague 11694, Czech Republic
[2] Ceske Budejovice Hosp, Dept Nucl Med, Ceske Budejovice, Czech Republic
关键词
Osteoporosis; Celiac disease; Phenylketonuria; Crohn disease; Rheumatoid arthritis; Hyperthyreosis; BONE-MINERAL DENSITY; VITAMIN-D-RECEPTOR; CELIAC-DISEASE; INFLAMMATORY DISEASES; VERTEBRAL FRACTURES; ADULT PATIENTS; LIVER-DISEASE; RISK-FACTOR; METABOLISM; HEALTH;
D O I
10.33549/physiolres.934027
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Osteoporosis in chronic diseases is very frequent and pathogenetically varied. It complicates the course of the underlying disease by the occurrence of fractures, which aggravate the quality of life and increase the mortality of patients from the underlying disease. The secondary deterioration of bone quality in chronic diseases, such as diabetes of type 1 and type 2 and/or other endocrine and metabolic disorders, as well as inflammatory diseases, including rheumatoid arthritis - are mostly associated with structural changes to collagen, altered bone turnover, increased cortical porosity and damage to the trabecular and cortical microarchitecture. Mechanisms of development of osteoporosis in some inborn or acquired disorders are discussed.
引用
收藏
页码:S441 / S454
页数:14
相关论文
共 50 条
  • [31] Prevalence of and risk factors for osteoporosis in adults with acquired brain injury
    Smith, E.
    Comiskey, C.
    Carroll, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 (02) : 473 - 481
  • [32] Molecular Mechanisms of Osteoporosis in Inflammatory Rheumatic Diseases
    Neumann, E.
    AKTUELLE RHEUMATOLOGIE, 2012, 37 (04) : 254 - 259
  • [33] Liver Diseases and Osteoporosis
    Gaugg, M.
    Erlacher, L.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2011, 4 (01): : 14 - 19
  • [34] Osteoporosis and rheumatic diseases
    Maruotti, N.
    Corrado, A.
    Cantatore, F. P.
    REUMATISMO, 2014, 66 (02) : 125 - 135
  • [35] Osteoporosis in gastrointestinal diseases
    Franco, Carina Bertoldi
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (01) : 57 - 68
  • [36] The spectrum of opportunistic diseases complicating sarcoidosis
    Jamilloux, Yvan
    Valeyre, Dominique
    Lortholary, Olivier
    Bernard, Claire
    Kerever, Sebastien
    Lelievre, Lucie
    Neel, Antoine
    Broussolle, Christiane
    Seve, Pascal
    AUTOIMMUNITY REVIEWS, 2015, 14 (01) : 64 - 74
  • [37] Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
    Hiligsmann, M.
    Reginster, J. -Y.
    Tosteson, A. N. A.
    Bukata, S. V.
    Saag, K. G.
    Gold, D. T.
    Halbout, P.
    Jiwa, F.
    Lewiecki, E. M.
    Pinto, D.
    Adachi, J. D.
    Al-Daghri, N.
    Bruyere, O.
    Chandran, M.
    Cooper, C.
    Harvey, N. C.
    Einhorn, T. A.
    Kanis, J. A.
    Kendler, D. L.
    Messina, O. D.
    Rizzoli, R.
    Si, L.
    Silverman, S.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (01) : 45 - 57
  • [38] Editorial: Osteoporosis in Rheumatic Diseases, What's New?
    Ruaro, Barbara
    Guiducci, Serena
    da Silva, Jose A. P.
    Wade, Barbara
    Baratella, Elisa
    Confalonieri, Marco
    FRONTIERS IN MEDICINE, 2021, 8
  • [39] Markers of autoimmune liver diseases in postmenopausal women with osteoporosis
    Demirdal, Umit Secil
    Ciftci, Ihsan Hakki
    Kavuncu, Vural
    CLINICS, 2010, 65 (10) : 971 - 974
  • [40] Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis
    Lopez-Delgado, Laura
    Riancho-Zarrabeitia, Leyre
    Riancho, Jose A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (04) : 389 - 398